Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center and Kyleigh LiPira, CEO of the Melanoma Research F
Jun 3, 2022 ·
9m 15s
Download and listen anywhere
Download your favorite episodes and enjoy them, wherever you are! Sign up or log in now to access offline listening.
Description
Skin cancer remains the most common cancer in the U.S. despite preventative sun care measures like sunscreen use and UV-protective clothing. Fortunately, scientific advances have helped bring hope to patients...
show more
Skin cancer remains the most common cancer in the U.S. despite preventative sun care measures like sunscreen use and UV-protective clothing. Fortunately, scientific advances have helped bring hope to patients facing advanced melanoma. Dr. Jason Luke, Director of Cancer Immunotherapeutic Center at UPMC Hillman Cancer Center, and Kyleigh LiPira, Melanoma Research Foundation, First-of-its-Kind Dual immunotherapy treatment for advanced melanoma patients talk about a new treatment option and what it may mean for patients facing the disease.
show less
Information
| Author | BizTalkPodcasts |
| Organization | BizTalkPodcasts |
| Website | - |
| Tags |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company
